Hematological: Low all‐cause mortality and low occurrence of antimicrobial resistance in hematological patients with bacteremia receiving no antibacterial prophylaxis: a single‐center study
- 15 March 2012
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 88 (5) , 422-430
Abstract
Background: Bacteremia is a major cause of morbidity and mortality in patients with hematological malignancies.Objectives: The aim of this study was to define temporal trends in species distribution, antimicrobial susceptibility, and all‐cause mortality in bacteremic hospitalized patients receiving no antibacterial prophylaxis during chemotherapy‐induced neutropenia.Methods: A total of 677 clinical episodes of bacteremia were identified in 463 patients during 2002–2008, and the results were compared with those published from the same institution during 1980–86 and 1988–2001. No major changes in patient selection were introduced during this period.Results: Between 2002 and 2008, the dominating pathogens were Escherichia coli (18%), coagulase‐negative staphylococci (15%), viridans streptococci (14%), Klebsiella spp. (10%), and Enterococcus faecium (8%). The 7‐d crude mortality rate was 5.2%. Polymicrobial bacteremia was seen in 25.7% of the patients who died within 7 d and in 13.1% of the survivors (P = 0.04). Acquired resistance was rarely observed, but a statistically significant increase in ciprofloxacin resistance in E. coli was observed. Comparing 2002–2008 with historical data from the same institution, the proportion of Gram‐positive isolates remained stable at 53–55% from 1988.Conclusions: The avoidance of fluoroquinolone prophylaxis may have contributed to a stable proportion of Gram‐positive bacteremia. The crude mortality was low in an international perspective. Acquired resistance was uncommon, but ciprofloxacin resistance in E. coli increased significantly. We believe that an indiscriminate use of antibacterial prophylaxis could be avoided in neutropenic patients without a negative impact on mortality.Keywords
This publication has 40 references indexed in Scilit:
- Success Story of Targeted Therapy in Chronic Myeloid Leukemia: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2008Journal of Clinical Oncology, 2011
- Prevalence of antimicrobial resistant pathogens from blood cultures from Canadian hospitals: results of the CANWARD 2007–2009 studyDiagnostic Microbiology and Infectious Disease, 2011
- Survival Patterns in Patients With Hodgkin's Lymphoma With a Pre-Existing Hospital Discharge Diagnosis of Autoimmune DiseaseJournal of Clinical Oncology, 2010
- The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service researchBritish Journal of Haematology, 2010
- Incidence and clinical impact of extended-spectrum-β-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignanciesJournal of Infection, 2009
- Severe sepsis in autologous stem cell transplant recipients: Microbiological aetiology, risk factors and outcomeScandinavian Journal of Infectious Diseases, 2009
- Neutropenic fever and severe sepsis in adult acute myeloid leukemia (AML) patients receiving intensive chemotherapy: Causes and consequencesLeukemia & Lymphoma, 2008
- Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxisThe Hematology Journal, 2003
- Microbiological Findings in Febrile NeutropeniaArchives of Medical Research, 2000
- Risk Factors, Aetiology, Therapy and Outcome in 123 Episodes of Breakthrough Bacteraemia and Fungaemia during Antimicrobial Prophylaxis and Therapy in Cancer PatientsJournal of Medical Microbiology, 1997